01
Cultivation
Licensed Jamaican growers cultivate a defined cultivar under a Cultivator licence, with crop records kept from seed to harvest.
Cultivar identity, crop and lot records
Pharmaceutical supply
Standardised cannabinoid materials for pharmaceutical development.
We provide pharmaceutical companies with controlled, standardised cannabinoid materials and investigational products for preclinical research, clinical development and pharmaceutical manufacturing, supported by full analytical, quality, stability and international export documentation.
Positioning
Not medical cannabis. An investigational product platform.
Sponsors do not buy cannabis. They buy a defined material with a specification, a batch record and a data pack. Our operation is structured around that requirement rather than around retail product.
1GMP delta 9 THC API
2Defined formulation
3Fixed dose
4Batch specific CoA and stability
5Clinical trial material
Capability
What we can supply.
Each line below is supplied against a written specification, with quantity, cultivar and cannabinoid percentages declared on the export documentation.
| Capability | What we can supply |
|---|---|
| Pharmaceutical cannabis flower | Standardised THC and CBD chemovars |
| THC rich extracts | Defined THC concentration per millilitre |
| CBD and THC extracts | Fixed ratios including 1:1, 1:2 and 2:1 |
| Purified cannabinoids | Delta 9 THC, CBD and selected minor cannabinoids |
| Clinical trial material | Standardised investigational products |
| R&D material | Research quantities for universities and pharma |
| API and intermediates | Cannabinoid material for pharmaceutical formulation |
| Custom cultivation | Genetics and chemovars grown to sponsor specification |
Formulations
Fixed doses, defined ratios.
Formulation and format are agreed with the sponsor before cultivation begins, so the material matches the protocol rather than the harvest.
- THC dominant at 2.5 mg, 5 mg and 10 mg
- THC and CBD at 1:1, 1:2 and 2:1
- CBD dominant and low THC
- Purified delta 9 THC API
- Standardised full spectrum extract
Delivery formats
- Oral capsules
- Sublingual and oral solutions
- Bulk extract for onward formulation
- Dried flower for inhalation studies
Operational process
From a Jamaican field to a clinical trial site.
Scroll to follow a single batch through the supply chain. Every stage produces documentation that travels with the material.
01 / 09
02
Extraction
Harvested material is processed under a Processing licence into extract or purified cannabinoid material.
Bulk extract or API intermediate
03
Standardisation
Material is adjusted to a fixed concentration and formulation agreed with the sponsor, for example 20 mg per mL of delta 9 THC.
Defined formulation and fixed dose
04
Analytical testing
Accredited laboratories confirm identity, quality, purity, potency and consistency, plus contaminant and residual solvent screens.
Batch specific Certificate of Analysis
05
Batch release
Quality review of the batch record, specification and test data before the lot is released for supply.
Release documentation and CMC data pack
06
Stability programme
Retained samples are held under defined temperature and humidity conditions with scheduled testing intervals.
Stability data and shelf life statement
07
Export permit
Application to the Cannabis Licensing Authority for an export permit for medicinal, therapeutic or scientific purposes, with quantity, strain and cannabinoid percentages declared.
Jamaican export permit
08
Controlled transport
GDP compliant, temperature monitored freight under controlled drug transport conditions with a full chain of custody.
Chain of custody and shipping file
09
Licensed importer
The sponsor or importer receives the material under the destination country controlled drug, clinical trial and manufacturing authorisations.
Clinical trial material at the trial site
Operational process
From a Jamaican field to a clinical trial site.
01. Cultivation
Licensed Jamaican growers cultivate a defined cultivar under a Cultivator licence, with crop records kept from seed to harvest.
Cultivar identity, crop and lot records
02. Extraction
Harvested material is processed under a Processing licence into extract or purified cannabinoid material.
Bulk extract or API intermediate
03. Standardisation
Material is adjusted to a fixed concentration and formulation agreed with the sponsor, for example 20 mg per mL of delta 9 THC.
Defined formulation and fixed dose
04. Analytical testing
Accredited laboratories confirm identity, quality, purity, potency and consistency, plus contaminant and residual solvent screens.
Batch specific Certificate of Analysis
05. Batch release
Quality review of the batch record, specification and test data before the lot is released for supply.
Release documentation and CMC data pack
06. Stability programme
Retained samples are held under defined temperature and humidity conditions with scheduled testing intervals.
Stability data and shelf life statement
07. Export permit
Application to the Cannabis Licensing Authority for an export permit for medicinal, therapeutic or scientific purposes, with quantity, strain and cannabinoid percentages declared.
Jamaican export permit
08. Controlled transport
GDP compliant, temperature monitored freight under controlled drug transport conditions with a full chain of custody.
Chain of custody and shipping file
09. Licensed importer
The sponsor or importer receives the material under the destination country controlled drug, clinical trial and manufacturing authorisations.
Clinical trial material at the trial site
Quality and regulatory
Controls the regulator expects.
Regulators require cannabis derived investigational drugs to be controlled for identity, quality, purity, potency and consistency. That is a manufacturing and documentation problem, and it is where most of our work sits.
Analytical and quality
- Identity and cultivar confirmation
- Potency by cannabinoid profile
- Contaminant, microbial and heavy metal screens
- Residual solvent testing on extracts
Stability and retention
- Scheduled stability testing intervals
- Defined storage conditions
- Retained samples per batch
- Shelf life statements for the data pack
Export and controlled drug
- CLA export permit applications
- Quantity, strain and cannabinoid declarations
- Controlled drug transport conditions
- Coordination with the importer of record
A Jamaican permit is a starting point, not an entry ticket.
A Jamaican export permit does not on its own allow material into the United Kingdom, European Union, United States, Canada or Australia. The sponsor or importer needs the relevant controlled drug, clinical trial, manufacturing and import authorisations in the destination country. We plan the corridor with the importer from the outset so the documentation on both sides matches.
See our clinical trial supply model
Tell us the specification and we will build to it.
Send us the cannabinoid profile, concentration, dose and quantity your programme requires. We will come back with a feasibility view, a documentation list and an indicative timeline.